The FDA has approved the first in a new class of drugs to fight AIDS. The drug, called Fuzeon, prevents HIV from invading and killing immune system cells, something that will benefit patients with late stage AIDS who are becoming resistant to other treatments.
Fuzeon will be given by injection twice a day, and it is expected to be available by the end of March.
Fuzeon won't be available for all AIDS patients. Experts say it's hefty pricetag and limited quantities will keep it from reaching many of the patients whom it could benefit. It is manufactured by Roche Pharmaceuticals and Trimeris. The drug should be available by the end of the month.